77% buyers of institutions opening or closing positions this quarter
25 more new buyers than exits, ownership rose 0.00 percentage points vs the prior quarter, and no widely-followed fund managers in the top 25.
77% buyers of institutions opening or closing positions this quarter
200.0% institutional ownership
FCPM III SERVICES portfolio allocation
Institutional ownership vs Biotechnology peers
No Form 4 insider transactions on file
Latest positioning in VOR across 13F flow, ownership shift, marquee holders, and holder-count growth.
Ranked by reported Q1 2026 13F market value
Share of total reported institutional value in VOR held by the largest 10 / 25 filers.
| # | Institution | Shares Held | Market Value | QoQ Change | Ownership % | % of Fund |
|---|---|---|---|---|---|---|
| 1 | TCG Crossover Management, LLC | 5.7M | $96.5M | β | 82.772% | 2.76% |
| 2 | RA CAPITAL MANAGEMENT, L.P. | 5.4M | $96.4M | 0.0% | 78.860% | 1.02% |
| 3 | FCPM III SERVICES B.V. | 4.1M | $73.5M | +13.8% | 60.073% | 10.17% |
| 4 | VR Adviser, LLC | 3.0M | $54.3M | +56.5% | 44.379% | 2.03% |
| 5 | Frazier Life Sciences Management, L.P. | 2.5M | $45.4M | 0.0% | 37.117% | 1.17% |
| 6 | Caligan Partners LP | 1.9M | $34.3M | +108.1% | 28.087% | 2.29% |
| 7 | Paradigm Biocapital Advisors LP | 1.8M | $31.2M | 0.0% | 25.533% | 0.64% |
| 8 | GREAT POINT PARTNERS LLC | 1.8M | $31.2M | +27.7% | 25.533% | 7.18% |
| 9 | FMR LLC | 1.5M | $27.5M | -39.1% | 22.464% | 0.00% |
| 10 | VANGUARD CAPITAL MANAGEMENT LLC | 1.4M | $25.6M | β | 20.912% | 0.00% |
| 11 | MARSHALL WACE, LLP | 1.2M | $20.6M | β | 16.827% | 0.02% |
| 12 | STATE STREET CORP | 1.1M | $20.0M | +1128.4% | 16.319% | 0.00% |
| 13 | NEXTBio Capital Management LP | 1000K | $17.8M | 0.0% | 14.590% | 8.28% |
| 14 | BlackRock, Inc. | 795K | $14.2M | +70.7% | 11.596% | 0.00% |
| 15 | Logos Global Management LP | 750K | $13.4M | +650.0% | 10.943% | 0.67% |
| 16 | Rosalind Advisors, Inc. | 700K | $12.5M | β | 10.213% | 5.02% |
| 17 | BOOTHBAY FUND MANAGEMENT, LLC | 556K | $9.9M | β | 8.108% | 0.13% |
| 18 | UBS Group AG | 488K | $8.7M | +67.2% | 7.125% | 0.00% |
| 19 | BRAIDWELL LP | 467K | $8.3M | β | 6.810% | 0.28% |
| 20 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 409K | $7.3M | -70.2% | 5.965% | 0.00% |
| 21 | GEODE CAPITAL MANAGEMENT, LLC | 343K | $6.1M | +84.4% | 4.998% | 0.00% |
| 22 | Clearline Capital LP | 326K | $5.8M | β | 4.759% | 0.30% |
| 23 | SPHERA FUNDS MANAGEMENT LTD. | 322K | $5.7M | -21.6% | 4.697% | 0.91% |
| 24 | Laurion Capital Management LP | 319K | $5.7M | +0.4% | 4.649% | 0.25% |
| 25 | Propel Bio Management, LLC | 315K | $5.6M | β | 4.589% | 3.52% |
denotes a marquee investor (Buffett, Burry, ARK, Tiger Global, Pershing Square, Baupost and other widely-followed managers). β% of Fundβ shows how much of that investorβs total 13F portfolio is invested in VOR β a direct measure of their conviction.
Filings activity in VOR during Q1 2026, grouped by how each filer changed its position.
3 quarters of 13F filings Β· Ξ columns show change vs prior quarter
| Quarter | Inst. Holders | Ξ Holders | Ownership % | Ξ Ownership | Total 13F Value | Ξ Value |
|---|---|---|---|---|---|---|
| Q1 2026 | 79 | +46% | 199.99% | +0.00 pp | $719M | +106% |
| Q4 2025 | 54 | +50% | 199.99% | +8.71 pp | $350M | +89% |
| Q3 2025 | 36 | β | 191.28% | β | $185M | β |
Source: SEC 13F institutional filings. Ownership % requires market cap data and will show once linked. Ξ columns compare to the immediately prior filed quarter.
No recent Form 4 insider transactions on file for VOR.
Quick answers to the most common questions about buying VOR stock.
Based on Q1 2026 13F filings, institutional ownership of Vor Biopharma Inc. stands at 200.0%, held across 79 reporting institutions.
TCG Crossover Management, LLC is the largest reported institutional holder of VOR, with approximately 5,673,078 shares worth $0.10B as of Q1 2026.
No marquee "smart money" managers (Berkshire, Burry, ARK, Tiger Global, Pershing Square, Baupost, etc.) currently appear among the top 25 institutional holders of VOR.
Our composite Smart Money Score for VOR is 49 out of 100 (Neutral). It combines net institutional buying activity, ownership shift, marquee investor presence, and holder-count growth.
36 institutions opened new positions in VOR during Q1 2026, while 11 fully exited. 37 added to existing positions and 5 trimmed.
VOR institutional ownership rose by 0.00 percentage points quarter-over-quarter, with a net change of +25 holders.
The top 10 institutions account for 71.7% of all reported 13F value in VOR, and the top 25 account for 94.2%.
All data is sourced from SEC Form 13F filings, which institutional investment managers with at least $100M in assets are required to file each quarter. We process every 13F filing from EDGAR and recompute the aggregates after each cycle. Insider transactions are sourced from Form 4 filings.